Nanae Sugasaki
Nagasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET.
Journal: Journal of thoracic disease
Published: May 31, 2025
Nivolumab plus ipilimumab with chemotherapy for non-small cell lung cancer with untreated brain metastases: A multicenter single-arm phase 2 trial (NIke, LOGiK 2004).
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 15, 2024
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).
Journal: Translational lung cancer research
Published: June 15, 2024
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: May 12, 2024
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.
Journal: Thoracic cancer
Published: August 16, 2023
Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use.
Journal: The American journal of case reports
Published: July 31, 2019
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
Journal: Cancer chemotherapy and pharmacology
Published: January 24, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026